Trading Window

Ref: NEPHROPLUS/SE/88 September 25, 2026 To To BSE Limited National Stock Exchange of India Limited P.J. Towers, Dalal Street, 5th Floor, Exchange Plaza, Bandra (E), Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 544647 Scrip Symbol: NEPHROPLUS Through: BSE Listing Centre Through: NEAPS Sub: Closure of trading window Pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, read with the Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives, the Trading Window for dealing in the securities of the Company shall remain closed for all Designated Persons and their Immediate Relatives with effect from October 01, 2026, on account of the existence of Unpublished Price Sensitive Information, including the financial results of the Company for the quarter and half year ending September 30, 2026. The Trading Window shall remain closed until 48 hours after the declaration of the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026. This intimation is being made available on the website of the Company www.nephroplus.com For Nephrocare Health Services Limited (Formerly Nephrocare Health Services Private Limited) Kishore Kathri Company Secretary & Head Legal ICSI Mo. No. F9895